ArticleFrontiers in pharmacology2021

Modeling and Simulation to Support Phase Ib/IIa Dose Selection for WBP216, A Long Half-Life Fully Human Monoclonal Antibody Against Interleukin-6.

Xiange Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.